$SUJA

PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD. purchased $4.1M of SUJA (indirect holdings)

PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD. purchased 567,900 indirectly-held shares of SUJA LIFE, INC. (SUJA) at an average of $7.16 ($6.73–$7.63, $4.06M total) across 3 trades over 2026-08-18 to 2026-08-20.

Original reporting
SEC EDGAR · PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD.
Published Aug 20, 2026, 9:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 10:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SUJA
Bullish
high confidence
Mentioned
$SUJA
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SUJABullishMed
01

Why it matters

The disclosed purchase adds to the insider's ownership, indicating confidence and may influence short‑term trading sentiment.

02

Market read

Form 4 insider purchase is a primary disclosure that can affect SUJA's stock price.

03

What to watch

Potential upcoming financing or strategic partnership not disclosed.

Relevance 7/10Novelty 6/10Timing: post‑market filing

Background

SUJA Life, Inc. is a consumer health company listed on Nasdaq. Insider purchases are reported via Form 4 filings.

Company-level read

Ticker impact

$SUJABullishHigh confidence
Context

Form 4 filing shows PAINE SCHWARTZ FOOD CHAIN FUND V GP purchased 567,900 shares for $4.06M, increasing its stake to 9.79M shares.

Expected impact

Potential modest price lift in the near term as market absorbs the insider buying signal.

Evidence & confidence

The purchase is sizable for a micro‑cap, executed via open market trades over three days, indicating a deliberate accumulation.

Market effects

Signals confidence in the health‑food supplement sector, may lift peers.

Limited to US micro‑cap market.

Minimal global impact.

Counterpoint

Insider buying could be a window‑dressing move ahead of a future dilution event.

Key entities

  • PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD.

    Insider holder acquiring additional shares.

  • SUJA Life, Inc.

    Issuer of the shares purchased.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SUJAMed

Suja Defies Grocery Slowdown With Double-Digit Sales Growth in Q2

Suja Life, Inc. (Nasdaq: SUJA) reported Q2 net sales up 11.6% year over year to $83.9 million, citing volume growth and improved distribution. Gross profit increased 9.9% to $39.2 million, or 46.7% of sales. The company raised its 2026 outlook to $360 to $369 million net sales from $326.6 million in 2025.

$SUJAMed

SUJA LIFE, INC. (SUJA): Results of Operations and Financial Condition

SUJA LIFE, INC. (SUJA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sujalifeq22026earningsrele.htm EX-99.1 Document Suja Life Reports Second Quarter 2026 Financial Results Net sales increased 11.6% year-over-year to $83.9 million Updates fiscal year 2026 outlook OCEANSIDE, CA, August 4, 2026 – Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,

$SUJAMedAI 9/10

Suja Life Reports First Quarter 2026 Financial Results

Suja Life (NASDAQ: SUJA) reported first-quarter 2026 net sales of $107.1 million, up 22.5% year over year from $87.4 million. Adjusted EBITDA rose 66.3% to $25.0 million, with margin expanding to 23.4%. Net income was $7.7 million versus a prior-year net loss. The company initiated 2026 guidance: net sales $367–$371 million and Adjusted EBITDA $70–$72 million.

$SUJAMed

Suja Life (NASDAQ:SUJA) Upgraded to “Strong-Buy” at Evercore

Evercore upgraded Suja Life (NASDAQ:SUJA) to a “strong-buy” rating in a Monday research note, according to Zacks.com. Other firms also initiated coverage: Goldman Sachs set a $31 target and a “buy,” Jefferies set a $25 target and a “buy,” and William Blair rated “outperform.” MarketBeat data show a consensus “Buy” and average target $26.67.